ロード中...
Molecular basis for passive immunotherapy of Alzheimer's disease
Amyloid aggregates of the amyloid-β (Aβ) peptide are implicated in the pathology of Alzheimer's disease. Anti-Aβ monoclonal antibodies (mAbs) have been shown to reduce amyloid plaques in vitro and in animal studies. Consequently, passive immunization is being considered for treating Alzheimer...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2007
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1994138/ https://ncbi.nlm.nih.gov/pubmed/17895381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0705888104 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|